Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 25;147(1):62.
doi: 10.1007/s00401-024-02702-4.

Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice

Tuancheng Feng  1 , Huan Du  1 , Cha Yang  1 , Ya Wang  1 , Fenghua Hu  2
Affiliations

Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice

Tuancheng Feng et al. Acta Neuropathol. .

Abstract

TMEM106B, a gene encoding a lysosome membrane protein, is tightly associated with brain aging, hypomyelinating leukodystrophy, and multiple neurodegenerative diseases, including frontotemporal lobar degeneration with TDP-43 aggregates (FTLD-TDP). Recently, TMEM106B polymorphisms have been associated with tauopathy in chronic traumatic encephalopathy (CTE) and FTLD-TDP patients. However, how TMEM106B influences Tau pathology and its associated neurodegeneration, is unclear. Here we show that loss of TMEM106B enhances the accumulation of pathological Tau, especially in the neuronal soma in the hippocampus, resulting in severe neuronal loss in the PS19 Tau transgenic mice. Moreover, Tmem106b-/- PS19 mice develop significantly increased abnormalities in the neuronal cytoskeleton, autophagy-lysosome activities, as well as glial activation, compared with PS19 and Tmem106b-/- mice. Together, our findings demonstrate that loss of TMEM106B drastically exacerbates Tau pathology and its associated disease phenotypes, and provide new insights into the roles of TMEM106B in neurodegenerative diseases.

Keywords: Lysosome; Neurodegeneration; PS19; TMEM106B; Tau.

PubMed Disclaimer

Update of

Similar articles

See all similar articles

Cited by

References

    1. Ahmad F, Mein H, Jing Y, Zhang H, Liu P (2021) Behavioural functions and cerebral blood flow in a P301S tauopathy mouse model: a time-course study. Int J Mol Sci. https://doi.org/10.3390/ijms22189727 - DOI - PubMed - PMC
    1. Alonso AD, Cohen LS, Corbo C, Morozova V, ElIdrissi A, Phillips G et al (2018) Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability. Front Cell Neurosci 12:338. https://doi.org/10.3389/fncel.2018.00338 - DOI - PubMed - PMC
    1. Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C et al (2019) Role of Tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci 11:204. https://doi.org/10.3389/fnagi.2019.00204 - DOI - PubMed - PMC
    1. Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N et al (2017) Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain 140:3286–3300. https://doi.org/10.1093/brain/awx243 - DOI - PubMed - PMC
    1. Bemiller SM, McCray TJ, Allan K, Formica SV, Xu G, Wilson G et al (2017) TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener 12:74. https://doi.org/10.1186/s13024-017-0216-6 - DOI - PubMed - PMC

LinkOut - more resources